Liang X - Search Results

1

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.

Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. Tang D, et al. Among authors: liang x. Oncogene. 2010 Sep 23;29(38):5299-310. doi: 10.1038/onc.2010.261. Epub 2010 Jul 12. Oncogene. 2010. PMID: 20622903 Free PMC article.

2

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Liang X, De Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer Stolz D, Basse P, Wang T, Van Houten B, Zeh HJ 3rd, Lotze MT. Liang X, et al. Cancer Res. 2012 Jun 1;72(11):2791-801. doi: 10.1158/0008-5472.CAN-12-0320. Epub 2012 Apr 3. Cancer Res. 2012. PMID: 22472122 Free PMC article.

3

Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity.

Lotze MT, Buchser WJ, Liang X. Lotze MT, et al. Among authors: liang x. Autophagy. 2012 Aug;8(8):1264-6. doi: 10.4161/auto.20752. Epub 2012 Jun 4. Autophagy. 2012. PMID: 22660171

4

HMGB1: The Central Cytokine for All Lymphoid Cells.

Li G, Liang X, Lotze MT. Li G, et al. Among authors: liang x. Front Immunol. 2013 Mar 20;4:68. doi: 10.3389/fimmu.2013.00068. eCollection 2013. Front Immunol. 2013. PMID: 23519706 Free PMC article.

5

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.

Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M, Billiar T. Lotze MT, et al. Among authors: liang x. Immunol Rev. 2007 Dec;220:60-81. doi: 10.1111/j.1600-065X.2007.00579.x. Immunol Rev. 2007. PMID: 17979840 Review.

6

Ethyl pyruvate administration inhibits hepatic tumor growth.

Liang X, Chavez AR, Schapiro NE, Loughran P, Thorne SH, Amoscato AA, Zeh HJ, Beer-Stolz D, Lotze MT, de Vera ME. Liang X, et al. J Leukoc Biol. 2009 Sep;86(3):599-607. doi: 10.1189/jlb.0908578. J Leukoc Biol. 2009. PMID: 19584311

7

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. Yan W, et al. Among authors: liang x. Hepatology. 2012 Jun;55(6):1863-75. doi: 10.1002/hep.25572. Hepatology. 2012. PMID: 22234969 Free PMC article.

8

The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Romo de Vivar Chavez A, de Vera ME, Liang X, Lotze MT. Romo de Vivar Chavez A, et al. Among authors: liang x. Med Oncol. 2009;26 Suppl 1:3-12. doi: 10.1007/s12032-008-9162-z. Epub 2009 Jan 16. Med Oncol. 2009. PMID: 19148593 Review.

9

Pharmacologic administration of interleukin-2.

Chavez AR, Buchser W, Basse PH, Liang X, Appleman LJ, Maranchie JK, Zeh H, de Vera ME, Lotze MT. Chavez AR, et al. Among authors: liang x. Ann N Y Acad Sci. 2009 Dec;1182:14-27. doi: 10.1111/j.1749-6632.2009.05160.x. Ann N Y Acad Sci. 2009. PMID: 20074271

10

Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

Tang S, Bonaroti J, Unlu S, Liang X, Tang D, Zeh HJ, Lotze MT. Tang S, et al. Among authors: liang x. Pancreas. 2013 Jul;42(5):740-59. doi: 10.1097/MPA.0b013e3182854ab0. Pancreas. 2013. PMID: 23774697 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,521 results

Search Page

Filters